Judie B. Alimonti

100 Sussex Dr
Ottawa, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Zika virus crosses an in vitro human blood brain barrier model.

Zika virus crosses an in vitro human blood brain barrier model.

Journal: Fluids and barriers of the CNS

Published: February 05, 2018

Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.

Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: May 08, 2017

Immune Response to Marburg Virus Angola Infection in Nonhuman Primates.

Immune Response to Marburg Virus Angola Infection in Nonhuman Primates.

Journal: The Journal of infectious diseases

Published: May 11, 2015

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.

Journal: The New England journal of medicine

Published: April 02, 2015

Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.

Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.

Journal: JAMA

Published: March 06, 2015

VSVΔG/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection.

VSVΔG/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection.

Journal: Viral immunology

Published: December 11, 2014

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Journal: Nature

Published: August 05, 2014

Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents.

Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents.

Journal: Vaccine

Published: April 30, 2014

Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory.

Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory.

Journal: Scientific reports

Published: April 29, 2014

mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms.

mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms.

Journal: Science translational medicine

Published: October 18, 2013

Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs.

Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs.

Journal: Journal of virology

Published: April 26, 2013

Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates.

Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates.

Journal: Science translational medicine

Published: November 02, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026